“…Globally, the seroprevalence of toxocariasis varies widely by climate and geographical region, being generally lower in industrialized temperate countries such as the USA (3.6%) ( Bradbury et al, 2020 ) and China (5.1%) ( Wang et al, 2020 ), and higher in lower-middle-income tropical countries such as Nigeria (92.4%) ( Ikotun et al, 2020 ), Honduras (88.6%) ( Hernández et al, 2020 ), Ghana (62.0%) ( Boyko et al, 2020 ), and Vietnam (59.0%) ( Van De et al, 2020 ). Our study reported a relatively low toxocariasis seroprevalence rate of 2.5% among allergic patients, 80% of whom were non-Kuwaiti residents originating from lower-middle-income South/Southeast Asian tropical countries (i.e., the Philippines, Sri Lanka and Bangladesh).…”